Literature DB >> 17917968

Quantitative expression analysis in peripheral blood of patients with chronic myeloid leukaemia: correlation between HMGA2 expression and white blood cell count.

B Meyer1, D Krisponeit, C Junghanss, H Murua Escobar, J Bullerdiek.   

Abstract

The architectural transcription factor HMGA2 is highly expressed during embryogenesis but scarcely detectable in non-dividing adult cells. Previously, HMGA2 re-expression was detected in blood from CML patients by conventional RT-PCR, while blood samples from healthy volunteers were HMGA2 negative. Using the sensitive method of real-time quantitative RT-PCR, herein HMGA2 expression was detectable not only in peripheral blood from leukaemia patients but also in blood from healthy donors. Statistical analysis revealed a highly significant correlation between white blood cell count and HMGA2 transcript levels. The results indicate that up-regulation of HMGA2 expression is correlated to the undifferentiated phenotype of leukaemic cells accumulating during progression of chronic phase to blast crisis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17917968     DOI: 10.1080/10428190701559116

Source DB:  PubMed          Journal:  Leuk Lymphoma        ISSN: 1026-8022


  10 in total

1.  Extended survival of glioblastoma patients after chemoprotective HSC gene therapy.

Authors:  Jennifer E Adair; Brian C Beard; Grant D Trobridge; Tobias Neff; Jason K Rockhill; Daniel L Silbergeld; Maciej M Mrugala; Hans-Peter Kiem
Journal:  Sci Transl Med       Date:  2012-05-09       Impact factor: 17.956

Review 2.  Non-small-cell lung cancer harbouring mutations in the EGFR kinase domain.

Authors:  Rafael Rosell; Teresa Morán; Enric Carcereny; Vanessa Quiroga; Miguel Angel Molina; Carlota Costa; Susana Benlloch; Miquel Tarón
Journal:  Clin Transl Oncol       Date:  2010-02       Impact factor: 3.405

3.  HMGA1 gene expression level in cancer tissue and blood samples of non-small cell lung cancer (NSCLC) patients: preliminary report.

Authors:  Lias Saed; Ewa Balcerczak; Mariusz Łochowski; Ewa Olechnowicz; Aleksandra Sałagacka-Kubiak
Journal:  Mol Genet Genomics       Date:  2022-08-10       Impact factor: 2.980

4.  Downregulation of HMGA2 by Small Interfering RNA Affects the Survival, Migration, and Apoptosis of Prostate Cancer Cell Line.

Authors:  Shima Khajouee; Elham Baghbani; Ali Mohammadi; Behzad Mansoori; Dariush Shanehbandi; Khalil Hajiasgharzadeh; Behzad Baradaran
Journal:  Adv Pharm Bull       Date:  2021-04-03

5.  Gene expressions of HMGI-C and HMGI(Y) are associated with stage and metastasis in colorectal cancer.

Authors:  Meng-Lin Huang; Chou-Chan Chen; Li-Ching Chang
Journal:  Int J Colorectal Dis       Date:  2009-07-17       Impact factor: 2.571

6.  Detection of high mobility group A2 specific mRNA in the plasma of patients affected by epithelial ovarian cancer.

Authors:  Francesca Galdiero; Annunciata Romano; Rosa Pasquinelli; Sandro Pignata; Stefano Greggi; Emilia Vuttariello; Anna Maria Bello; Celeste Calise; Cono Scaffa; Carmela Pisano; Nunzia Simona Losito; Alfredo Fusco; Daniela Califano; Gennaro Chiappetta
Journal:  Oncotarget       Date:  2015-08-07

7.  HMGA2 regulates acute myeloid leukemia progression and sensitivity to daunorubicin via Wnt/β-catenin signaling.

Authors:  Shuo Yang; Yueli Gu; Genjie Wang; Qingzhu Hu; Shuxia Chen; Yong Wang; Mingfeng Zhao
Journal:  Int J Mol Med       Date:  2019-06-05       Impact factor: 4.101

8.  Lin28 promotes transformation and is associated with advanced human malignancies.

Authors:  Srinivas R Viswanathan; John T Powers; William Einhorn; Yujin Hoshida; Tony L Ng; Sara Toffanin; Maureen O'Sullivan; Jun Lu; Letha A Phillips; Victoria L Lockhart; Samar P Shah; Pradeep S Tanwar; Craig H Mermel; Rameen Beroukhim; Mohammad Azam; Jose Teixeira; Matthew Meyerson; Timothy P Hughes; Josep M Llovet; Jerald Radich; Charles G Mullighan; Todd R Golub; Poul H Sorensen; George Q Daley
Journal:  Nat Genet       Date:  2009-05-31       Impact factor: 38.330

9.  Generation and characterisation of a canine EGFP-HMGA2 prostate cancer in vitro model.

Authors:  Saskia Willenbrock; Siegfried Wagner; Nicola Reimann-Berg; Mohammed Moulay; Marion Hewicker-Trautwein; Ingo Nolte; Hugo Murua Escobar
Journal:  PLoS One       Date:  2014-06-10       Impact factor: 3.240

10.  Silencing of HMGA2 reverses retardance of cell differentiation in human myeloid leukaemia.

Authors:  Li Tan; Hongfa Xu; Guoshu Chen; Xiaoping Wei; Baodan Yu; Jingmei Ye; Lihua Xu; Huo Tan
Journal:  Br J Cancer       Date:  2018-01-02       Impact factor: 7.640

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.